BioCurex, Inc.(fka BOCX)

[opportunityknocking]

I agree. I think in retrospect, the negotiations should have been for a several million dollar upfront fee. This would have allowed us to avoid toxic funding and further dilution. It would also have caused Abbott to get this to the market much sooner. When I look at the doctors involved with our company, past and present, it is the most knowledgeable modern medicine has to offer.